Smart hydration during surgery may shield Seniors' brains
NCT ID NCT07438249
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 180 older adults (65+) having major abdominal cancer surgery to see if giving fluids based on real-time body signals (goal-directed fluid therapy) helps prevent short-term memory and thinking problems after surgery. Patients received either this personalized approach or standard care. The main goal was to compare changes in thinking test scores from before surgery to one and seven days after. The study aims to find better ways to support brain health during surgery in elderly patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
180 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of geriatric patients (aged 65 and older) scheduled for elective major abdominal cancer surgery at the University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Participants will be selected from patients who meet the inclusion criteria and provide informed consent during their preoperative evaluation in the anesthesiology clinic
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 65 years (geriatric patients) * Scheduled for elective major abdominal cancer surgery * American Society of Anesthesiologists (ASA) Physical Status I-IV * Eastern Cooperative Oncology Group (ECOG/WHO/Zubrod) performance status ≥ 2 * Ability to complete cognitive assessments * Provision of written informed consent Exclusion Criteria: * Severe cardiac dysfunction (Cardiac Index ≤ 2.2 L/min/m²) * History of neurological or psychiatric disorders (e.g., dementia, Alzheimer's disease) * Use of medications that significantly affect cognitive function * Severe hepatic or renal failure * Prior chemotherapy or radiotherapy before surgery * Intraoperative or perioperative blood transfusion * Prolonged mechanical ventilation (inability to extubate immediately after surgery) * Pre-existing cognitive impairment (baseline Mini-Mental State Examination \[MMSE\] score \< 24)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Abdominal neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea
Ankara, Yenimahalle, 06200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 24 sensors map muscle oxygen after ACL surgery
- Can engineered immune cells outsmart Drug-Resistant ovarian cancer?
- Ultrasound could guide safer fluid dosing after heart surgery
- Heart-Guided exercise may keep aging bodies stronger
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a simple walk test reveal hidden health risks in aging?